Atreca, Inc. (BCEL) Covered Calls

You can sell covered calls on Atreca, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BCEL (prices last updated Tue 4:16 PM ET):

Atreca, Inc. (BCEL) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.09 0.00 0.09 0.09 42K - 0.0
Covered Calls For Atreca, Inc. (BCEL)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 0.5 0.00 0.09 0.0% 0.0%
Jun 21 0.5 0.00 0.09 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Atreca, Inc., a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody in clinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It has a strategic research collaboration with Merck Sharp & Dohme Corp. to identify the antigenic targets of select antibodies discovered with potential utility in oncology. Atreca, Inc. was founded in 2010 and is headquartered in South San Francisco, California.